Chantalle Metekohy is EMEA Medical Advisor Oncology within Janssen and responsible for the development and implementation of the Medical Affairs strategy for Europe, Middle East, and Africa (EMEA) for bladder cancer and tumor agnostic indications.

She has extensive experience in developing Evidence Generation plans for innovative therapies and she is the Study responsible scientist of ESFURN (European Study of FGFR in Urothelial neoplasm). 

She is trained as a Doctor in Veterinary medicine and joined the pharmaceutical industry 10 years ago gaining experience in roles with expanding responsibilities within Medical Affairs across different therapeutic areas.